Unknown

Dataset Information

Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee population.


ABSTRACT: Clinical and economic outcomes from a pharmacogenomics-enriched comprehensive medication management program were evaluated over 26 months in a self-insured U.S. employee population (n = 452 participants; n = 1500 controls) using propensity matched pre-post design with adjusted negative binomial and linear regression models. After adjusting for baseline covariates, program participation was associated with 39% fewer inpatient (p = 0.05) and 39% fewer emergency department (p = 0.002) visits, and with 21% more outpatient visits (p < 0.001) in the follow-up period compared to the control group. Results show pharmacogenomics-enriched comprehensive medication management can favorably impact healthcare utilization in a self-insured employer population by reducing emergency department and inpatien

SUBMITTER: Fragala MS 

PROVIDER: S-EPMC11446811 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature